Lastly, if active forms of MMP-2 and/or MMP-9 were present in ALS, a final goal was to determine how their levels compare to those of other inflammatory and/or neurodegenerative diseases. This evidence concerns the gene MMP9 and amyotrophic lateral sclerosis.